Justin Mao

Title: Innovations by Justin Mao

Introduction

Justin Mao is an accomplished inventor based in North Reading, MA (US). He has made significant contributions to the field of metabolic disorder treatments through his innovative patents. With a total of two patents to his name, Mao is recognized for his work in developing compounds that target specific biochemical pathways.

Latest Patents

Mao's latest patents include "Cyclic ether DGAT1 inhibitors" and "Cyclic bridgehead ether DGAT1 inhibitors." Both inventions relate to compounds that are useful for treating disorders mediated by acyl coA-diacylglycerol acyl transferase 1 (DGAT1). These compounds are particularly relevant for addressing metabolic disorders. The patents also provide methods for treating such disorders, along with compounds and compositions for their treatment.

Career Highlights

Justin Mao is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions for complex health issues. His expertise in the field has contributed to the advancement of therapeutic options for patients suffering from metabolic disorders.

Collaborations

Mao collaborates with talented colleagues, including Sejal Patel and Qian Liu. Their combined efforts in research and development have fostered a productive environment for innovation.

Conclusion

Justin Mao's contributions to the field of metabolic disorder treatments through his patents highlight his role as a significant inventor. His work at Novartis AG and collaborations with fellow researchers further enhance the impact of his innovations.